Gyre Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Gyre Therapeutics, Inc. (GYRE) reported Earnings Per Share, Basic and Diluted of -$0.46 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-09
- Gyre Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.46.
- Gyre Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.80.
- Gyre Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.64.
- Gyre Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.79.
- Gyre Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.87.
- Gyre Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.93.
- Gyre Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$4.60.
- Gyre Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$2.68.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.46 10-Q · filed 2022-05-09 | |||||||
| 2021-12-31 | -$2.87 10-K · filed 2022-03-31 | |||||||
| 2021-09-30 | -$0.80 10-Q · filed 2021-11-12 | -$1.44 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$2.23 10-Q · filed 2021-11-12 | -$3.06 derived: net income ÷ weighted average shares · filed 2022-11-14 | ||||
| 2021-06-30 | -$0.64 10-Q · filed 2021-08-05 | -$1.42 10-Q · filed 2021-08-05 | -$2.25 derived: net income ÷ weighted average shares · filed 2022-08-15 | -$2.98 derived: net income ÷ weighted average shares · filed 2022-08-15 | ||||
| 2021-03-31 | -$0.79 10-Q · filed 2022-05-09 | -$1.64 derived: net income ÷ weighted average shares · filed 2022-05-09 | -$2.37 derived: net income ÷ weighted average shares · filed 2022-05-09 | -$3.30 derived: net income ÷ weighted average shares · filed 2022-05-09 | ||||
| 2020-12-31 | -$0.85 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$1.58 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$2.52 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$2.93 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$0.73 10-Q · filed 2021-11-12 | -$1.67 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$2.05 10-Q · filed 2021-11-12 | -$3.06 derived: net income ÷ weighted average shares · filed 2021-11-12 | ||||
| 2020-06-30 | -$0.96 10-Q · filed 2021-08-05 | -$1.31 10-Q · filed 2021-08-05 | -$2.35 derived: net income ÷ weighted average shares · filed 2021-08-05 | -$3.37 derived: net income ÷ weighted average shares · filed 2021-08-05 | ||||
| 2020-03-31 | -$0.28 10-Q · filed 2021-05-06 | -$1.33 derived: net income ÷ weighted average shares · filed 2021-05-06 | -$2.36 derived: net income ÷ weighted average shares · filed 2021-05-06 | -$3.49 derived: net income ÷ weighted average shares · filed 2021-05-06 | ||||
| 2019-12-31 | -$1.13 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$2.19 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$3.34 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$4.60 10-K · filed 2021-03-04 | ||||
| 2019-09-30 | -$1.06 10-Q · filed 2020-11-05 | -$2.21 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$3.47 10-Q · filed 2020-11-05 | -$4.37 derived: net income ÷ weighted average shares · filed 2020-11-05 | ||||
| 2019-06-30 | -$1.15 10-Q · filed 2020-08-06 | -$2.41 10-Q · filed 2020-08-06 | -$3.32 derived: net income ÷ weighted average shares · filed 2020-08-06 | -$3.96 derived: net income ÷ weighted average shares · filed 2020-08-06 | ||||
| 2019-03-31 | -$1.26 10-Q · filed 2020-05-11 | -$2.17 derived: net income ÷ weighted average shares · filed 2020-05-11 | -$2.81 derived: net income ÷ weighted average shares · filed 2020-05-11 | -$3.36 derived: net income ÷ weighted average shares · filed 2020-05-11 | ||||
| 2018-12-31 | -$0.91 derived: net income ÷ weighted average shares · filed 2020-02-20 | -$1.55 derived: net income ÷ weighted average shares · filed 2020-02-20 | -$2.09 derived: net income ÷ weighted average shares · filed 2020-02-20 | -$2.68 10-K · filed 2020-02-20 | ||||
| 2018-09-30 | -$0.64 10-Q · filed 2019-11-07 | -$1.19 derived: net income ÷ weighted average shares · filed 2019-11-07 | -$1.75 10-Q · filed 2019-11-07 | -$2.67 derived: net income ÷ weighted average shares · filed 2019-11-07 | ||||
| 2018-06-30 | -$0.54 10-Q · filed 2019-08-01 | -$1.10 10-Q · filed 2019-08-01 | -$2.03 derived: net income ÷ weighted average shares · filed 2019-08-01 | -$3.10 derived: net income ÷ weighted average shares · filed 2019-08-01 | ||||
| 2018-03-31 | -$0.56 10-Q · filed 2019-05-02 | -$1.59 derived: net income ÷ weighted average shares · filed 2019-05-02 | -$2.79 derived: net income ÷ weighted average shares · filed 2019-05-02 | -$4.86 derived: net income ÷ weighted average shares · filed 2019-05-02 | ||||
| 2017-12-31 | -$1.26 derived: net income ÷ weighted average shares · filed 2019-03-08 | -$2.60 derived: net income ÷ weighted average shares · filed 2019-03-08 | -$5.03 derived: net income ÷ weighted average shares · filed 2019-03-08 | -$7.45 10-K · filed 2019-03-08 | ||||
| 2017-09-30 | -$1.34 10-Q · filed 2018-11-01 | -$3.82 derived: net income ÷ weighted average shares · filed 2018-11-01 | -$6.49 10-Q · filed 2018-11-01 | -$9.50 derived: net income ÷ weighted average shares · filed 2018-11-01 | ||||
| 2017-06-30 | -$2.53 10-Q · filed 2018-08-02 | -$5.82 10-Q · filed 2018-08-02 | -$9.52 derived: net income ÷ weighted average shares · filed 2018-08-02 | -$14.11 derived: net income ÷ weighted average shares · filed 2018-08-02 | ||||
| 2017-03-31 | -$4.57 10-Q · filed 2018-05-03 | -$9.24 derived: net income ÷ weighted average shares · filed 2018-05-03 | -$15.21 derived: net income ÷ weighted average shares · filed 2018-05-03 | -$21.46 derived: net income ÷ weighted average shares · filed 2018-05-03 | ||||
| 2016-12-31 | -$4.68 derived: net income ÷ weighted average shares · filed 2018-03-19 | -$10.71 derived: net income ÷ weighted average shares · filed 2018-03-19 | -$17.02 derived: net income ÷ weighted average shares · filed 2018-03-19 | -$21.75 10-K · filed 2018-03-19 | ||||
| 2016-09-30 | -$6.04 10-Q · filed 2017-11-02 | -$0.40 10-Q · filed 2016-11-03 | -$12.37 derived: net income ÷ weighted average shares · filed 2017-11-02 | -$17.10 10-Q · filed 2017-11-02 | -$1.14 10-Q · filed 2016-11-03 | |||
| 2016-06-30 | -$6.33 10-Q · filed 2017-08-03 | -$0.42 10-Q · filed 2016-08-04 | -$11.05 10-Q · filed 2017-08-03 | -$0.74 10-Q · filed 2016-08-04 | ||||
| 2016-03-31 | -$4.71 10-Q · filed 2017-05-11 | -$0.31 10-Q · filed 2016-05-05 | ||||||
| 2015-12-31 | -$0.45 10-K · filed 2016-03-09 | -$49.99 10-K · filed 2017-03-08 | -$3.33 10-K · filed 2016-03-09 | |||||
| 2015-09-30 | -$0.93 10-Q · filed 2016-11-03 | -$4.65 10-Q · filed 2016-11-03 | ||||||
| 2015-06-30 | -$4.60 10-Q · filed 2016-08-04 | -$0.13 10-Q · filed 2015-07-31 | -$12.26 10-Q · filed 2016-08-04 | -$0.33 10-Q · filed 2015-07-31 | ||||
| 2015-03-31 | -$7.67 10-Q · filed 2016-05-05 | -$0.20 10-Q · filed 2015-05-07 | ||||||
| 2014-12-31 | -$3.51 10-K · filed 2016-03-09 | -$17.99 10-K · filed 2016-03-09 | -$0.97 10-K · filed 2015-03-16 | |||||
| 2014-09-30 | -$4.08 10-K · filed 2016-03-09 | -$0.14 10-Q · filed 2014-11-06 | -$14.49 10-Q · filed 2015-11-05 | -$0.83 10-Q · filed 2014-11-06 | ||||
| 2014-06-30 | -$0.22 8-K/A · filed 2015-10-23 | -$0.40 8-K/A · filed 2015-10-23 | -$0.69 10-Q · filed 2014-08-07 | |||||
| 2014-03-31 | -$4.75 10-K · filed 2016-03-09 | -$0.44 10-Q · filed 2014-05-08 | ||||||
| 2013-12-31 | -$27.29 10-K · filed 2016-03-09 | -$1.39 10-K · filed 2014-03-14 | ||||||
| 2013-09-30 | -$0.38 10-Q · filed 2014-11-06 | -$0.99 10-Q · filed 2014-11-06 | ||||||
| 2013-06-30 | -$0.37 10-Q · filed 2014-08-07 | -$0.61 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | -$0.24 10-Q · filed 2014-05-08 | |||||||
| 2012-12-31 | -$0.21 10-K · filed 2015-03-16 | |||||||
| 2011-12-31 | -$0.27 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |